Retrovirology (Apr 2005)

Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection <it>in vitro </it>without blocking gp120/CCR5 interaction

  • Lever Andrew ML,
  • Grainger David J

DOI
https://doi.org/10.1186/1742-4690-2-23
Journal volume & issue
Vol. 2, no. 1
p. 23

Abstract

Read online

Abstract Background Cellular infection with human immunodeficiency virus (HIV) both in vitro and in vivo requires a member of the chemokine receptor family to act as a co-receptor for viral entry. However, it is presently unclear to what extent the interaction of HIV proteins with chemokine receptors generates intracellular signals that are important for productive infection. Results In this study we have used a recently described family of chemokine inhibitors, termed BSCIs, which specifically block chemokine-induced chemotaxis without affecting chemokine ligands binding to their receptors. The BSCI termed Peptide 3 strongly inhibited CCR5 mediated HIV infection of THP-1 cells (83 ± 7% inhibition assayed by immunofluoresence staining), but had no effect on gp120 binding to CCR5. Peptide 3 did not affect CXCR4-dependent infection of Jurkat T cells. Conclusion These observations suggest that, in some cases, intracellular signals generated by the chemokine coreceptor may be required for a productive HIV infection.

Keywords